Atlas Trials

Neo-Adjuvant Chemotherapy (TAC) With or Without Zoledronic Acid in Treating HER2-negative Breast Cancer Patients

Clinical trial NCT01099436 · COMPLETED

Trial details

NCT number
NCT01099436
Sponsor
Borstkanker Onderzoek Groep
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-04-01
Primary completion
2012-04-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.